Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 32 Records) |
| Query Trace: Colorectal Neoplasms and AKT1[original query] |
|---|
| Effect of classification based on combination of mutation and methylation in colorectal cancer prognosis. Oncology reports 2011 Mar 25 (3): 789-94. Aoyagi Haruhiko, Iida Satoru, Uetake Hiroyuki, Ishikawa Toshiaki, Takagi Yoko, Kobayashi Hirotoshi, Higuchi Tetsuro, Yasuno Masamichi, Enomoto Masayuki, Sugihara Kenic |
| Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. Nutrition and cancer 2011 Nov 63 (8): 1226-34. Slattery Martha L, Lundgreen Abbie, Herrick Jennifer S, Caan Bette J, Potter John D, Wolff Roger |
| PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer. Clinical colorectal cancer 2012 Jun 11 (2): 143-50. Sood Arjun, McClain Danielle, Maitra Radhashree, Basu-Mallick Atrayee, Seetharam Raviraja, Kaubisch Andreas, Rajdev Lakshmi, Mariadason John M, Tanaka Kathryn, Goel Sanj |
| Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Apr 19 (7): 1902-12. Peeters Marc, Oliner Kelly S, Parker Alex, Siena Salvatore, Van Cutsem Eric, Huang Jing, Humblet Yves, Van Laethem Jean-Luc, André Thierry, Wiezorek Jeffrey, Reese David, Patterson Scott |
| Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients. Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5599-603. Tong Lin, Yang Xue-Xi, Liu Min-Feng, Yao Guang-Yu, Dong Jian-Yu, Ye Chang-Sheng, Li Mi |
| Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801). Oncology 2014 87 (1): 7-20. Soeda Hiroshi, Shimodaira Hideki, Gamoh Makio, Ando Hideaki, Isobe Hideki, Suto Takeshi, Takahashi Shin, Kakudo Yuichi, Amagai Kenji, Mori Takahiro, Watanabe Mika, Yamaguchi Takuhiro, Kato Shunsuke, Ishioka Chikas |
| KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment. Molecular and clinical oncology 2014 May 2 (3): 356-362. Soeda Hiroshi, Shimodaira Hideki, Watanabe Mika, Suzuki Takao, Gamo Makio, Takahashi Masanobu, Komine Keigo, Kato Shunsuke, Ishioka Chikas |
| Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis. Annals of surgical oncology 2015 Oct . Chang Shih-Ching, Lin Pei-Ching, Lin Jen-Kou, Lin Chien-Hsing, Yang Shung-Haur, Liang Wen-Yi, Chen Wei-Shone, Jiang Jeng-K |
| CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer. International journal of clinical oncology 2016 Jul . Zhang Xiaofei, Shimodaira Hideki, Soeda Hiroshi, Komine Keigo, Takahashi Hidekazu, Ouchi Kota, Inoue Masahiro, Takahashi Masanobu, Takahashi Shin, Ishioka Chikas |
| Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients. Medical oncology (Northwood, London, England) 2016 Jul 33 (7): 71. Li Zhe-Zhen, Bai Long, Wang Feng, Zhang Zi-Chen, Wang Fang, Zeng Zhao-Lei, Zeng Jun-Bo, Zhang Dong-Sheng, Wang Feng-Hua, Wang Zhi-Qiang, Li Yu-Hong, Shao Jian-Yong, Xu Rui-H |
| Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response. Oncotarget 2016 Apr . Li Zhe-Zhen, Wang Feng, Zhang Zi-Chen, Wang Fang, Zhao Qi, Zhang Dong-Sheng, Wang Feng-Hua, Wang Zhi-Qiang, Luo Hui-Yan, He Ming-Ming, Wang De-Shen, Jin Ying, Ren Chao, Qiu Miao-Zhen, Ren Jian, Pan Zhi-Zhong, Li Yu-Hong, Shao Jiao-Yong, Xu Rui-H |
| Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients. Oncotarget 2016 Apr 7 (16): 22257-70. Hsu Hung-Chih, Thiam Tan Kien, Lu Yen-Jung, Yeh Chien Yuh, Tsai Wen-Sy, You Jeng Fu, Hung Hsin Yuan, Tsai Chi-Neu, Hsu An, Chen Hua-Chien, Chen Shu-Jen, Yang Tsai-She |
| EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Sep 39 (9): 1010428317724517. Alvarez Karin, Orellana Paulina, Villarroel Cynthia, Contreras Luis, Kawachi Hiroshi, Kobayashi Maki, Wielandt Ana Maria, De la Fuente Marjorie, Triviño Juan Carlos, Kronberg Udo, Carvallo Pilar, López-Köstner Francis |
| Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer. International journal of molecular sciences 2017 Jul 18 (7): . Chang Chu-Cheng, Lin Pei-Ching, Lin Chun-Chi, Lan Yuan-Tzu, Lin Hung-Hsin, Lin Chien-Hsing, Yang Shung-Haur, Liang Wen-Yi, Chen Wei-Shone, Jiang Jeng-Kai, Lin Jen-Kou, Chang Shih-Chi |
| Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk. PloS one 2017 10 12 (10): e0186296. Jung Su Yon, Rohan Thomas, Strickler Howard, Bea Jennifer, Zhang Zuo-Feng, Ho Gloria, Crandall Carol |
| Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer cell international 2018 9 18 131. Fassan Matteo, Vianello Luca, Sacchi Diana, Fanelli Giuseppe N, Munari Giada, Scarpa Marco, Cappellesso Rocco, Loupakis Fotios, Lanza Cristiano, Salmaso Roberta, Mescoli Claudia, Valeri Nicola, Agostini Marco, D'Angelo Edoardo, Lonardi Sara, Pucciarelli Salvatore, Veronese Nicola, Luchini Claudio, Rugge Massi |
| Differences in gene mutations according to gender among patients with colorectal cancer. World journal of surgical oncology 2018 7 16 (1): 128. Tsai Yi-Jian, Huang Sheng-Chieh, Lin Hung-Hsin, Lin Chun-Chi, Lan Yuan-Tzu, Wang Huann-Sheng, Yang Shung-Haur, Jiang Jeng-Kai, Chen Wei-Shone, Lin Tzu-Chen, Lin Jen-Kou, Chang Shih-Chi |
| Association of Genetic Variants of Small Non-Coding RNAs with Survival in Colorectal Cancer. International journal of medical sciences 2018 15 (3): 217-222. Pao Jiunn-Bey, Lu Te-Ling, Ting Wen-Chien, Chen Lu-Min, Bao Bo-Yi |
| Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 9 37 (33): 3099-3110. Morano Federica, Corallo Salvatore, Lonardi Sara, Raimondi Alessandra, Cremolini Chiara, Rimassa Lorenza, Murialdo Roberto, Zaniboni Alberto, Sartore-Bianchi Andrea, Tomasello Gianluca, Racca Patrizia, Clavarezza Matteo, Adamo Vincenzo, Perrone Federica, Gloghini Annunziata, Tamborini Elena, Busico Adele, Martinetti Antonia, Palermo Federica, Loupakis Fotios, Milione Massimo, Fucà Giovanni, Di Bartolomeo Maria, de Braud Filippo, Pietrantonio Filip |
| Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer. The oncologist 2019 Jul . Chen Ming-Huang, Chang Shih-Ching, Lin Pei-Ching, Yang Shung-Haur, Lin Chun-Chi, Lan Yuan-Tzu, Lin Hung-Hsin, Lin Chien-Hsing, Lai Jiun-I, Liang Wen-Yi, Lu Meng-Lun, Yang Muh-Hwa, Chao Y |
| Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy. BMC cancer 2019 Mar 19 (1): 255. Harada Kazuaki, Okamoto Wataru, Mimaki Sachiyo, Kawamoto Yasuyuki, Bando Hideaki, Yamashita Riu, Yuki Satoshi, Yoshino Takayuki, Komatsu Yoshito, Ohtsu Atsushi, Sakamoto Naoya, Tsuchihara Katsu |
| Clinicopathological and molecular differences in colorectal cancer according to location. The International journal of biological markers 2019 Mar 1724600818807164. Hsu Yu-Lun, Lin Chun-Chi, Jiang Jeng-Kai, Lin Hung-Hsin, Lan Yuan-Tzu, Wang Huann-Sheng, Yang Shung-Haur, Chen Wei-Shone, Lin Tzu-Chen, Lin Jen-Kou, Lin Pei-Ching, Chang Shih-Chi |
| Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers. Pathology, research and practice 2019 2 215 (5): 957-962. Cappellesso Rocco, Lo Mele Marcello, Munari Giada, Rosa-Rizzotto Erik, Guido Ennio, De Lazzari Franca, Pilati Pierluigi, Tonello Marco, Farinati Fabio, Realdon Stefano, Fassan Matteo, Rugge Massi |
| Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis. Cancer medicine 2019 Nov . Ye Zu-Lu, Qiu Miao-Zhen, Tang Tao, Wang Fang, Zhou Yi-Xin, Lei Meng-Jie, Guan Wen-Long, He Cai-Y |
| Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients. International journal of clinical oncology 2019 1 24 (2): 141-152. Gao Xian Hua, Yu Guan Yu, Hong Yong Gang, Lian Wei, Chouhan Hanumant, Xu Yi, Liu Lian Jie, Bai Chen Guang, Zhang W |
| AKT1 Polymorphism (rs10138227) and Risk of Colorectal Cancer in Moroccan Population: A Case Control Study. Asian Pacific journal of cancer prevention : APJCP 2020 Nov 21 (11): 3165-3170. Allam Loubna, Arrouchi Housna, Ghrifi Fatima, El Khazraji Abdelhak, Kandoussi Ilham, Bendahou Mohammed Amine, El Amri Hamid, El Absi Mohamed, Ibrahimi Azeddi |
| Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma. Frontiers in oncology 2021 3 11 620146. Lan Yuan-Tzu, Chang Shih-Ching, Lin Pei-Ching, Lin Chun-Chi, Lin Hung-Hsin, Huang Shen-Chieh, Lin Chien-Hsing, Liang Wen-Yi, Chen Wei-Shone, Jiang Jeng-Kai, Lin Jen-Kou, Yang Shung-Ha |
| Impact of AKT1 polymorphism on DNA damage, BTG2 expression, and risk of colorectal cancer development. Radiology and oncology 2022 Aug 56 (3): 336-345. Zubair Hina, Khan Zahid, Imran Muhamm |
| Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy. JCO precision oncology 2022 5 6 e2200037. Randon Giovanni, Maddalena Giulia, Germani Marco Maria, Pircher Chiara Carlotta, Manca Paolo, Bergamo Francesca, Giordano Mirella, Sposetti Caterina, Montagna Aldo, Vetere Guglielmo, Zambelli Luca, Rasola Cosimo, Boccaccino Alessandra, Pagani Filippo, Ambrosini Margherita, Massafra Marco, Fontanini Gabriella, Milione Massimo, Fassan Matteo, Cremolini Chiara, Lonardi Sara, Pietrantonio Filip |
| KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania. Medicine 2022 Oct 101 (40): e30979. Brinzan Costel Stelian, Aschie Mariana, Cozaru Georgeta Camelia, Deacu Mariana, Dumitru Eugen, Burlacu Ionut, Mitroi An |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: